🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/08/1987 | 10,53 | 10,60 | 10,47 | 10,52 | -0,06% | 1,26% | 11.827.728 |
| 11/08/1987 | 10,44 | 10,59 | 10,40 | 10,52 | +0,89% | 1,78% | 14.419.642 |
| 10/08/1987 | 10,20 | 10,43 | 10,17 | 10,43 | +2,67% | 2,53% | 19.618.560 |
| 07/08/1987 | 10,07 | 10,19 | 10,05 | 10,16 | +1,52% | 1,45% | 10.605.341 |
| 06/08/1987 | 9,90 | 10,01 | 9,86 | 10,01 | +1,34% | 1,47% | 5.804.453 |
| 05/08/1987 | 9,93 | 9,96 | 9,83 | 9,87 | +0,07% | 1,27% | 6.232.666 |
| 04/08/1987 | 9,92 | 9,96 | 9,81 | 9,87 | -1,00% | 1,54% | 6.623.150 |
| 03/08/1987 | 9,90 | 10,03 | 9,90 | 9,97 | -0,66% | 1,34% | 7.047.590 |
| 31/07/1987 | 10,07 | 10,07 | 10,01 | 10,03 | -0,26% | 0,66% | 5.676.178 |
| 30/07/1987 | 10,04 | 10,07 | 9,97 | 10,06 | +0,40% | 1,06% | 9.237.701 |
| 29/07/1987 | 9,97 | 10,04 | 9,93 | 10,02 | +0,47% | 1,13% | 9.899.827 |
| 28/07/1987 | 9,83 | 9,99 | 9,73 | 9,97 | +1,97% | 2,63% | 22.448.160 |
| 27/07/1987 | 9,52 | 9,81 | 9,52 | 9,78 | +2,50% | 3,06% | 7.277.731 |
| 24/07/1987 | 9,55 | 9,58 | 9,50 | 9,54 | +0,00% | 0,76% | 3.212.539 |
| 23/07/1987 | 9,59 | 9,60 | 9,52 | 9,54 | -0,21% | 0,83% | 5.908.205 |
| 22/07/1987 | 9,60 | 9,62 | 9,52 | 9,56 | +0,21% | 1,10% | 6.489.216 |
| 21/07/1987 | 9,64 | 9,67 | 9,44 | 9,54 | -1,10% | 2,47% | 9.558.389 |
| 20/07/1987 | 9,65 | 9,69 | 9,62 | 9,65 | -0,55% | 0,76% | 9.232.042 |
| 17/07/1987 | 9,75 | 9,83 | 9,66 | 9,70 | -0,07% | 1,70% | 15.951.398 |
| 16/07/1987 | 9,63 | 9,72 | 9,58 | 9,71 | +2,02% | 1,44% | 11.727.749 |
| 15/07/1987 | 9,46 | 9,54 | 9,44 | 9,52 | +0,07% | 1,12% | 8.620.848 |
| 14/07/1987 | 9,26 | 9,52 | 9,25 | 9,51 | +2,72% | 2,86% | 8.441.640 |
| 13/07/1987 | 9,33 | 9,33 | 9,22 | 9,26 | -0,85% | 1,21% | 7.958.722 |
| 10/07/1987 | 9,39 | 9,41 | 9,34 | 9,34 | -0,63% | 0,78% | 5.151.758 |
| 09/07/1987 | 9,38 | 9,43 | 9,36 | 9,40 | +0,00% | 0,71% | 8.126.611 |
| 08/07/1987 | 9,31 | 9,40 | 9,25 | 9,40 | +0,92% | 1,57% | 9.226.382 |
| 07/07/1987 | 9,26 | 9,36 | 9,25 | 9,31 | +0,50% | 1,15% | 9.064.152 |
| 06/07/1987 | 9,42 | 9,42 | 9,25 | 9,26 | -1,48% | 1,83% | 10.282.766 |
| 02/07/1987 | 9,28 | 9,43 | 9,28 | 9,40 | +2,01% | 1,64% | 12.987.864 |
| 01/07/1987 | 8,99 | 9,22 | 8,99 | 9,22 | +1,98% | 2,65% | 13.263.278 |